These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 35577881)

  • 1. Determining KLF14 tertiary structure and diagnostic significance in brain cancer progression.
    Zahra K; Shabbir M; Badshah Y; Trembley JH; Badar Z; Khan K; Afsar T; Almajwal A; Alruwaili NW; Razak S
    Sci Rep; 2022 May; 12(1):8039. PubMed ID: 35577881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross talk of tumor protein D52 (TPD52) with KLF9, PKCε, and MicroRNA 223 in ovarian cancer.
    Khan K; Zafar S; Badshah Y; Ashraf NM; Rafiq M; Danish L; Shabbir M; Trembley JH; Afsar T; Almajwal A; Razak S
    J Ovarian Res; 2023 Oct; 16(1):202. PubMed ID: 37833790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CircTADA2A suppresses the progression of colorectal cancer via miR-374a-3p/KLF14 axis.
    Li Z; Yao H; Wang S; Li G; Gu X
    J Exp Clin Cancer Res; 2020 Aug; 39(1):160. PubMed ID: 32799891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KLF14/miR-1283/TFAP2C axis inhibits HER2-positive breast cancer progression via declining tumor cell proliferation.
    Chen XZ; He WX; Luo RG; Xia GJ; Zhong JX; Chen QJ; Huang YY; Guan YX
    Mol Carcinog; 2023 Apr; 62(4):532-545. PubMed ID: 36752341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-suppressive microRNA-34a inhibits breast cancer cell migration and invasion via targeting oncogenic TPD52.
    Li G; Yao L; Zhang J; Li X; Dang S; Zeng K; Zhou Y; Gao F
    Tumour Biol; 2016 Jun; 37(6):7481-91. PubMed ID: 26678891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. microRNA-218 inhibits prostate cancer cell growth and promotes apoptosis by repressing TPD52 expression.
    Han G; Fan M; Zhang X
    Biochem Biophys Res Commun; 2015 Jan; 456(3):804-9. PubMed ID: 25511701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosomal Circ-XIAP Promotes Docetaxel Resistance in Prostate Cancer by Regulating miR-1182/TPD52 Axis.
    Zhang H; Li M; Zhang J; Shen Y; Gui Q
    Drug Des Devel Ther; 2021; 15():1835-1849. PubMed ID: 33976535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The KLF14 Transcription Factor Regulates Glycolysis by Downregulating LDHB in Colorectal Cancer.
    Wu G; Yuan S; Chen Z; Chen G; Fan Q; Dong H; Ye F; Li J; Zhu X
    Int J Biol Sci; 2019; 15(3):628-635. PubMed ID: 30745849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Krüppel-like factor 14 inhibits atherosclerosis via mir-27a-mediated down-regulation of lipoprotein lipase expression in vivo.
    Xie W; Li L; Gong D; Zhang M; Lv YC; Guo DM; Zhao ZW; Zheng XL; Zhang DW; Dai XY; Yin WD; Tang CK
    Atherosclerosis; 2019 Oct; 289():143-161. PubMed ID: 31518965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-449b-5p suppresses cell proliferation, migration and invasion by targeting TPD52 in nasopharyngeal carcinoma.
    Yin W; Shi L; Mao Y
    J Biochem; 2019 Nov; 166(5):433-440. PubMed ID: 31350893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA DGCR5 represses the development of hepatocellular carcinoma by targeting the miR-346/KLF14 axis.
    Wang YG; Liu J; Shi M; Chen FX
    J Cell Physiol; 2018 Jan; 234(1):572-580. PubMed ID: 30216442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unravelling Structure, Localization, and Genetic Crosstalk of KLF3 in Human Breast Cancer.
    Khan K; Safi S; Abbas A; Badshah Y; Dilshad E; Rafiq M; Zahra K; Shabbir M
    Biomed Res Int; 2020; 2020():1354381. PubMed ID: 33490232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of MicroRNA-449 Promotes Migration and Invasion of Breast Cancer Cells by Targeting Tumor Protein D52 (TPD52).
    Zhang Z; Wang J; Gao R; Yang X; Zhang Y; Li J; Zhang J; Zhao X; Xi C; Lu X
    Oncol Res; 2017 May; 25(5):753-761. PubMed ID: 27983918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of TPD52 by antitumor microRNA-218 suppresses cancer cell migration and invasion in lung squamous cell carcinoma.
    Kumamoto T; Seki N; Mataki H; Mizuno K; Kamikawaji K; Samukawa T; Koshizuka K; Goto Y; Inoue H
    Int J Oncol; 2016 Nov; 49(5):1870-1880. PubMed ID: 27633630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-103a-3p Suppresses Cell Proliferation and Invasion by Targeting Tumor Protein D52 in Prostate Cancer.
    Ge J; Mao L; Xu W; Fang W; Wang N; Ye D; Dong Z; Guan H; Guan C
    J Invest Surg; 2021 Sep; 34(9):984-992. PubMed ID: 32166986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour-suppressive microRNA-224 inhibits cancer cell migration and invasion via targeting oncogenic TPD52 in prostate cancer.
    Goto Y; Nishikawa R; Kojima S; Chiyomaru T; Enokida H; Inoguchi S; Kinoshita T; Fuse M; Sakamoto S; Nakagawa M; Naya Y; Ichikawa T; Seki N
    FEBS Lett; 2014 May; 588(10):1973-82. PubMed ID: 24768995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The transcription factor KLF14 regulates macrophage glycolysis and immune function by inhibiting HK2 in sepsis.
    Yuan Y; Fan G; Liu Y; Liu L; Zhang T; Liu P; Tu Q; Zhang X; Luo S; Yao L; Chen F; Li J
    Cell Mol Immunol; 2022 Apr; 19(4):504-515. PubMed ID: 34983946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of MiR-145-5p promotes the growth and migration in LPS-treated HUVECs through inducing macrophage polarization to M2.
    Su D
    J Recept Signal Transduct Res; 2021 Oct; 41(5):434-441. PubMed ID: 32998623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EZH2-mediated inhibition of KLF14 expression promotes HSCs activation and liver fibrosis by downregulating PPARγ.
    Du Z; Liu M; Wang Z; Lin Z; Feng Y; Tian D; Xia L
    Cell Prolif; 2021 Jul; 54(7):e13072. PubMed ID: 34031939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. microRNA-328 is a favorable prognostic marker in human glioma via suppressing invasive and proliferative phenotypes of malignant cells.
    Yuan J; Zheng Z; Zheng Y; Lu X; Xu L; Lin L
    Int J Neurosci; 2016; 126(2):145-53. PubMed ID: 25562367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.